RxDoctor Payments DataLook up a doctor →

Richard Young

Urology · Myrtle Beach, SCNPI 1518948587

Payments from drug & device makers

$10,624in general payments, 2019–2025

Across 283 payments — averaging $37.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teleflex LLC$2K
  • Neotract Inc.$1K
  • Cipla USA Inc.$907
  • Dendreon Pharmaceuticals LLC$860
  • Boston Scientific$603
  • Antares Pharma, Inc.$445
  • plus $5K from 51 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Teleflex LLC16$1,833
Neotract Inc.4$1,323
Cipla USA Inc.3$907
Dendreon Pharmaceuticals LLC27$860
Boston Scientific11$603
Antares Pharma, Inc.28$445
Coloplast11$310
Procept Biorobotics Corporation4$254
Blue Earth Diagnostics7$250
Myriad Genetic Laboratories, Inc.14$243
AbbVie(2 entities)13$238
Urogen Pharma, Inc.4$231
Sumitomo Pharma America, Inc.11$214
Pfizer13$206
Johnson & Johnson7$198
Astellas Pharma US Inc9$184
Laborie Medical Technologies Corp.14$166
Theragenics Corporation1$158
Dornier Medtech America, Inc1$156
Foundation Medicine, Inc.2$137
SRS Medical Systems, Inc.2$126
Angiodynamics, Inc.1$120
Rochester Medical Corporation7$109
Medtronic(2 entities)4$91
Ferring Pharmaceuticals Inc.4$87
Endo Pharmaceuticals Inc.6$86
Bayer5$79
EMD Serono, Inc.5$70
Olympus America Inc.3$62
E.r. Squibb & Sons, L.L.C.3$61
Convatec Inc.3$60
Ambu Inc.2$57
Myovant Sciences Inc.3$49
C. R. Bard, Inc. & Subsidiaries1$47
Urovant Sciences Inc3$44
Bioprotect Medical, Inc.2$44
Halozyme Inc2$42
AVEO Pharmaceuticals, Inc.3$40
Stryker1$39
Eisai Inc.2$38
Progenics Pharmaceuticals, Inc.2$37
Verity Pharmaceuticals Inc.2$36
AstraZeneca2$33
Smith+Nephew1$29
ABC Home Medical Supply, Inc.2$29
Palette Life Sciences, Inc.1$23
Immunitybio, Inc.1$22
Tolmar Pharmaceuticals, Inc.1$19
Merck1$17
Sun Pharmaceutical Industries Inc.1$16
Telix Pharmaceuticals1$16
Clovis Oncology, Inc.1$16
Hollister Incorporated1$15
Zyla Life Sciences, Inc.1$14
Exelixis Inc.1$13
Baudax Bio Inc.1$11
Avadel Specialty Pharmaceuticals, LLC1$11

How this compares

$10,624 in reported general payments places this provider in the 75th percentile of 196 urology providers in South Carolina.

See all urology providers in South Carolina →

Medicare billing

Part B allowed, 2024
$678,275
Medicare patients
1,752
Services billed
23,251

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Myrtle Beach

See the full list for South Carolina →

Where these figures come from

Is this you, or does something look wrong? →